Clonal Evolution of B Cells in High-risk CLL After Idelalisib-rituximab

Clinical trial NCT02993536 · WITHDRAWN

Trial details

NCT number: NCT02993536
Sponsor: Abramson Cancer Center at Penn Medicine
Status: WITHDRAWN
Study type: OBSERVATIONAL

Chronic Lymphocytic Leukemia

Start date: 2015-11-01
Primary completion: 2017-11-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.